Related Experiment Videos
Coagulation factor deficiencies and pregnancy loss
1Institute of Thrombosis and Hemostasis, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Israel. aidainbal@hotmail.com
Seminars in Thrombosis and Hemostasis
|April 24, 2003
Summary
Pregnancy loss is linked to deficiencies in factor XIII (FXIII) and fibrinogen, crucial for placental health. Understanding these links aids in managing recurrent miscarriages and improving pregnancy outcomes.
Area of Science:
- Hematology
- Reproductive Medicine
- Obstetrics
Background:
- Coagulation factor deficiencies can impact pregnancy.
- Factor XIII (FXIII) and fibrinogen deficiencies are specifically associated with pregnancy loss.
- These deficiencies cause bleeding disorders and impaired wound healing from childhood.
Purpose of the Study:
- To discuss the causes of miscarriage in women with FXIII or fibrinogen deficiency.
- To advocate for appropriate treatment strategies for these patients.
- To highlight the role of FXIII and fibrinogen in successful pregnancy.
Main Methods:
- Literature review on coagulation factor deficiencies and pregnancy outcomes.
- Analysis of clinical data pertaining to FXIII and fibrinogen deficiency.
- Discussion of pathophysiological mechanisms linking these deficiencies to miscarriage.
Main Results:
- FXIII and fibrinogen are essential for placental implantation and maintenance of pregnancy.
- Deficiencies in FXIII or fibrinogen significantly increase the risk of recurrent spontaneous abortions.
- Impaired wound repair is a common comorbidity.
Conclusions:
- FXIII and fibrinogen deficiencies are critical factors contributing to pregnancy loss.
- Early diagnosis and appropriate management are vital for women with these conditions.
- Further research into targeted therapies can improve reproductive outcomes.